These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 26768967
1. Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model. Seo J, Lee C, Hwang HS, Kim B, Thao le Q, Lee ES, Oh KT, Lim JL, Choi HG, Youn YS. Pulm Pharmacol Ther; 2016 Feb; 36():53-61. PubMed ID: 26768967 [Abstract] [Full Text] [Related]
2. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. Lee C, Seo J, Hwang HS, Thao LQ, Lee S, Lee ES, Lee EH, Choi HG, Youn YS. Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446 [Abstract] [Full Text] [Related]
3. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues. Thao le Q, Byeon HJ, Lee C, Lee S, Lee ES, Choi HG, Park ES, Youn YS. Int J Pharm; 2016 Jan 30; 497(1-2):268-76. PubMed ID: 26657273 [Abstract] [Full Text] [Related]
4. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice. Trivedi R, Redente EF, Thakur A, Riches DW, Kompella UB. Nanotechnology; 2012 Dec 21; 23(50):505101. PubMed ID: 23186914 [Abstract] [Full Text] [Related]
6. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice. Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH. Int Immunopharmacol; 2014 Oct 21; 22(2):498-504. PubMed ID: 25111852 [Abstract] [Full Text] [Related]
7. An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model. Nishimoto T, Mlakar L, Takihara T, Feghali-Bostwick C. Int Immunopharmacol; 2015 Oct 21; 28(2):1102-5. PubMed ID: 26315492 [Abstract] [Full Text] [Related]
8. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity. Zhao L, Zhou Y, Gao Y, Ma S, Zhang C, Li J, Wang D, Li X, Li C, Liu Y, Li X. Int J Pharm; 2015 Apr 10; 483(1-2):180-7. PubMed ID: 25681723 [Abstract] [Full Text] [Related]
9. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis. Fujita M, Mizuta Y, Ikegame S, Ouchi H, Ye Q, Harada E, Inoshima I, Yoshimi M, Watanabe K, Nakanishi Y. Pulm Pharmacol Ther; 2008 Oct 10; 21(5):805-11. PubMed ID: 18655842 [Abstract] [Full Text] [Related]
19. The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice. Lee SH, Lee EJ, Lee SY, Kim JH, Shim JJ, Shin C, In KH, Kang KH, Uhm CS, Kim HK, Yang KS, Park S, Kim HS, Kim YM, Yoo TJ. Exp Lung Res; 2014 Apr 10; 40(3):117-25. PubMed ID: 24624895 [Abstract] [Full Text] [Related]
20. Albumin Based Nanomedicine for Enhancing Tacrolimus Safety and Lymphatic Targeting Efficiency. Zhang Y, Pan J, Li H, Yu D, Wu T, Wang L, Wang Y, Zhou L, Zheng S. J Biomed Nanotechnol; 2019 Jun 01; 15(6):1313-1324. PubMed ID: 31072438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]